BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2356 related articles for article (PubMed ID: 12509595)

  • 1. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe.
    Newell ML; Borja MC; Peckham C;
    Pediatrics; 2003 Jan; 111(1):e52-60. PubMed ID: 12509595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Growth of uninfected infants exposed to antiretrovirals born to HIV-infected woman].
    Fernández Ibieta M; Bellón Cano JM; Ramos Amador JT; González-Tomé MI; Guillén Martín S; Navarro Gómez M; De José MI; Beceiro J; Iglesias E; Prieto L; Santos MJ; Martínez Guardia N; Roa MA; Regidor J
    An Pediatr (Barc); 2009 Oct; 71(4):299-309. PubMed ID: 19660998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life.
    Gray L; Newell ML; Thorne C; Peckham C; Levy J;
    Pediatrics; 2001 Jul; 108(1):116-22. PubMed ID: 11433063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
    Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal growth of infants born to HIV-1-infected mothers in Belo Horizonte, Brazil.
    Fausto MA; Carneiro M; Antunes CM; Colosimo EA; Pinto JA
    Public Health Nutr; 2009 Jun; 12(6):783-8. PubMed ID: 18503725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
    Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M
    Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth.
    Villamor E; Mbise R; Spiegelman D; Hertzmark E; Fataki M; Peterson KE; Ndossi G; Fawzi WW
    Pediatrics; 2002 Jan; 109(1):E6. PubMed ID: 11773574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of human immunodeficiency virus infection on birthweight, and infant and child mortality in urban Malawi.
    Taha TE; Dallabetta GA; Canner JK; Chiphangwi JD; Liomba G; Hoover DR; Miotti PG
    Int J Epidemiol; 1995 Oct; 24(5):1022-9. PubMed ID: 8557435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
    Abrams EJ; Matheson PB; Thomas PA; Thea DM; Krasinski K; Lambert G; Shaffer N; Bamji M; Hutson D; Grimm K
    Pediatrics; 1995 Sep; 96(3 Pt 1):451-8. PubMed ID: 7651777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of Congo.
    Bailey RC; Kamenga MC; Nsuami MJ; Nieburg P; St Louis ME
    Int J Epidemiol; 1999 Jun; 28(3):532-40. PubMed ID: 10405861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of late in utero exposure to zidovudine in infants born to human immunodeficiency virus-infected mothers: Bangkok. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Chotpitayasunondh T; Vanprapar N; Simonds RJ; Chokephaibulkit K; Waranawat N; Mock P; Stat MA; Chuachoowong R; Young N; Mastro TD; Shaffer N
    Pediatrics; 2001 Jan; 107(1):E5. PubMed ID: 11134469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993.
    Lepage P; Msellati P; Hitimana DG; Bazubagira A; Van Goethem C; Simonon A; Karita E; Dequae-Merchadou L; Van de Perre P; Dabis F
    Pediatr Infect Dis J; 1996 Jun; 15(6):479-85. PubMed ID: 8783343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal vitamin A deficiency and child growth failure during human immunodeficiency virus infection.
    Semba RD; Miotti P; Chiphangwi JD; Henderson R; Dallabetta G; Yang LP; Hoover D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Mar; 14(3):219-22. PubMed ID: 9117453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal HIV infection, drug use, and growth of uninfected children in their first 3 years.
    Ross A; Raab GM; Mok J; Gilkison S; Hamilton B; Johnstone FD
    Arch Dis Child; 1995 Dec; 73(6):490-5. PubMed ID: 8546501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
    Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
    PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group.
    Moye J; Rich KC; Kalish LA; Sheon AR; Diaz C; Cooper ER; Pitt J; Handelsman E
    J Pediatr; 1996 Jan; 128(1):58-69. PubMed ID: 8551422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 118.